Evaluation of a 36 Gy elective node irradiation dose in anal cancer
- 1 August 2015
- journal article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 116 (2), 197-201
- https://doi.org/10.1016/j.radonc.2015.07.050
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/CisplatinJournal of Clinical Oncology, 2012
- Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 TrialJournal of Clinical Oncology, 2012
- Anal Canal Cancer: Management of Inguinal Nodes and Benefit of Prophylactic Inguinal Irradiation (CORS-03 Study)International Journal of Radiation Oncology*Biology*Physics, 2012
- Der ICRU-Report 83: Verordnung, Dokumentation und Kommunikation der fluenzmodulierten Photonenstrahlentherapie (IMRT)Strahlentherapie und Onkologie, 2012
- “Mind the Gap”—The Impact of Variations in the Duration of the Treatment Gap and Overall Treatment Time in the First UK Anal Cancer Trial (ACT I)International Journal of Radiation Oncology*Biology*Physics, 2011
- T1-2 anal carcinoma requires elective inguinal radiation treatment – The results of Trans Tasman Radiation Oncology Group study TROG 99.02Radiotherapy and Oncology, 2011
- Impact of Overall Treatment Time on Survival and Local Control in Patients With Anal Cancer: A Pooled Data Analysis of Radiation Therapy Oncology Group Trials 87-04 and 98-11Journal of Clinical Oncology, 2010
- Prognostic factors derived from a prospective database dictate clinical biology of anal cancerCancer, 2010
- Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014)European Journal of Cancer, 2009
- Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycinThe Lancet, 1996